Alexandria Forbes, MeiraGTx CEO (Hollie Adams/Bloomberg via Getty Images)
October 15, 2024 10:37 AM EDT
R&D
Cell/Gene Tx

MeiraGTx's stock ris­es on small Parkin­son's gene ther­a­py dataset

Max Gelman

Senior Editor

MeiraGTx un­veiled re­sults from a small dataset for its Parkin­son’s dis­ease gene ther­a­py on Tues­day morn­ing, caus­ing its shares $MGTX to jump by as much …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Ei­sai ter­mi­nates Phase 3 tri­al of Dravet drug, cit­ing re­cruit­ment chal­lenges

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Boston Phar­ma­ceu­ti­cals hits Phase 2 goals as it tries to keep up with MASH com­peti­tors

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times